◆ 会议时间：2023年10月26日至29日
◆ 会议地点：印度尼西亚 三宝垄（Semarang, Indonesia）

◆ 会议简介：

2023年第28届亚太血液和骨髓移植协会(APBMT)年会/大会将于2023年10月26日至29日在印度尼西亚三宝垄（垄川）举行，会议由亚太地区血液和骨髓移植协会(APBMT)主办。亚太血液和骨髓移植会议（APBMT年会）是亚太地区造血干细胞移植技术合作与学术交流重要的平台，每年在亚太地区不同的国家举办。

亚太地区血液和骨髓移植协会(APBMT)成立于1990年，是一个旨在分享有关造血干细胞移植(HSCT)信息并促进基础和临床研究合作的国际组织，由来自澳大利亚、中国、香港、印度、日本、韩国、马来西亚和中国台湾的移植医师于1990年发起成立。APBMT是世界血液和骨髓移植网络（WBMT）的创始成员之一。APBMT现包括22个国家/地区宣（澳大利亚，孟加拉国，柬埔寨，中国，香港，印度，印度尼西亚，伊朗，日本，韩国，马来西亚，蒙古，缅甸，尼泊尔，新西兰，巴基斯坦，菲律宾，新加坡，斯里兰卡，台湾，泰国和越南）。未经本站许可禁止复制摘录转载本站任何内容-领域国际医学会议网(lingyuint.com)

The 28th meeting of Asia Pacific Blood and Marrow Transplantation Group （APBMT2023）
Date: Oct. 26 (Thu) - Oct. 29 (Sun), 2023
Venue: PADMA and TENTREM, Semarang, Indonesia

摘要征文投稿：

Important Dates for Abstract Submissions

• Last date for abstract submission: August 3rd , 2023
• Notification of acceptance for oral/ E-poster presentations August 31st, 2023
• Last date for withdrawal of oral or poster presentation: September 15th, 2023
• Submission of E-posters (if being presented virtually) & videos for oral presentations (if being presented virtually): September 30th, 2023
• Presenting authors should register for the conference on or before the September 15th, 2023; else the abstract will be withdrawn from presentation.
• 点此提交摘要>>>Submit Abstract>>>

Guidelines for Submission of abstracts

You are invited to submit informative abstracts of up to 500 words (2800 characters) which would not include the title of the abstract, author affiliations and other headings like Aims, Methods, Results & Conclusions. The abstract may include a maximum of two tables and two graphs (which will not be included in 500 words (2800 characters) limit)

Abstracts must be submitted according to guidelines given below.

Abstract Title

Please write the title in Title Case (each main word has a capital letter). Do not use quotation marks.
e.g. The Results of the Research Case Study and Its Participants

Authors and Affiliations

The full names (no initials) of all participating authors (including yourself) must be included on the abstract. Please do not include degrees or professional titles.

Author Affiliations – please include the name of your organization, the city, the state, and the country.

Abstract Text

Abstracts that merely state the results that will be presented will be subject to rejection. All abstracts are subject to review by the Scientific Committee and acceptance into the program is not guaranteed. The Committee suggests that the abstract follow the format outlined below.

• Aims
• Methods
• Results
• Conclusions

Conflict of Interest Statement

If the research described in the abstract was supported by a commercial company, you must indicate the company’s role in analysing the data or preparing the abstract.
One of the following must appear at the bottom of the abstract:

“No conflict of interest to disclose”.

“This research was supported by __________. The company had no role in analysing the data or preparing the abstract.”

“This research was supported by __________. The company inserts free text describing company role in data analysis or abstract preparation.”

This conflict-of-interest statement is mandatory for all abstracts submitted and will appear wherever the abstracts are published. For oral presentations, a sample slide will be available to presenters for disclosure of conflicts of interest to be displayed as the first or second slide of their presentation

The abstracts must be submitted in one of the following sections:

• Leukemias
• Lymphoma/Myeloma
• Bone marrow failure syndromes including MDS.
• Infections
• Conditioning regimens
• GVHD
• Hemoglobinopathies, primary immune deficiency diseases and metabolic disorders.
• Pediatric transplantation
• Cell and Gene Therapy
• Basic Science
• Allied (Nursing, technical aspects such as graft processing, cryopreservation etc.)

Submission of the abstract carries with it an obligation to present the accepted abstract in person or virtually without any change in scientific content during the allotted time in the above conference. Withdrawal of presentation should be intimated to the scientific committee on or before September 15th 2023. If an author as the presenting author is not able to present the paper for the conference due to any reason, prior permission has to be obtained from the Program Committee regarding the change in the presenting author.

If the abstract is not submitted in the prescribed format, it will not be considered for review.

More than 1 abstract can be submitted by any individual/ author.

注册费：

Virtual Registration

– (Above rates are INCLUDE of VAT @11%, as applicable)

– *It is mandatory to mention APBMT membership number while registering for the conference, if registering as a member.

Notes:

• You can register online using your Debit/ Credit Card.
• Registration is mandatory for everyone, including faculty members.
• Resident/ Fellow/ Researcher/ Nurses/ Data Managers have to submit a certificate from their head of department/ institute.
• Accompanying Persons including spouses will not be allowed to attend/ enter scientific sessions.
• While your safety is of utmost importance, the committee/ organisers will take no responsibility for loss of belongings/ valuables or damage to your property.
• The registration fee does not include any travel cost, insurance, accommodation, sightseeing tours or airport transfers.

Cancellation Policy:

• You may send the cancellation requests to info@annualmeeting2023.apbmt.org , on or before 15th September 2023.
• In case of cancellation due to Covid or travel restrictions imposed by Governmental due to covid related issues , 75% of the registration amount will be refunded
• There will be no change of registrations from physical to virtual or vice-versa. In case of these changes, the delegate will have to cancel the registration under one and re-register for the other.

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。